Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-20-063780

Chief Executive Officer sold 1 shares at $25.00 ($25)

  • Chief Executive Officer acquired 1 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ballal Rahul D. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-14 Exercise or conversion : show line 1 in the form +1 $3.15 $3 1 D
2020-12-14 Sale : show line 2 in the form −1 $25.00 $25 0 D
Open-market sales · 1 sh · avg $25.00 · $25

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1 268,998 D
Loading xslF345X03/doc4.xml…